This inventor holds 1 USPTO granted patent. Top assignee: The Salk Institute. Active years: 1989.
Company Filing History:
Years Active: 1989
Title: The Innovations of Bryan D. Noe
Introduction
Bryan D. Noe is a notable inventor based in Decatur, GA (US). He has made significant contributions to the field of medical science, particularly in the development of insulin-selective somatostatin analogs. His work is crucial for advancing treatments for conditions such as insulinoma.
Latest Patents
Bryan D. Noe holds a patent for "Insulin-selective somatostatin analogs." This innovative compound, Anglerfish somatostatin-28, has the formula: ##STR1##. It is designed to be insulin-selective when administered in vivo, making it a valuable option for treating insulinoma. The 14-residue C-terminal peptide may also be utilized in therapeutic applications.
Career Highlights
Noe is affiliated with The Salk Institute, where he continues to push the boundaries of medical research. His work has garnered attention for its potential impact on diabetes treatment and related health issues.
Collaborations
One of his notable collaborators is Joachim Spiess, with whom he has worked on various research projects. Their combined expertise contributes to the advancement of innovative medical solutions.
Conclusion
Bryan D. Noe's contributions to the field of medical science through his patent and research at The Salk Institute highlight his role as an influential inventor. His work continues to pave the way for new treatments in the medical community.